|
|
News for Healthier Living
Teclistamab Extends Survival, Deepens Remissions in Relapsed Multiple Myeloma in Landmark International Trial
 NEJM/ASCO 2026: A global phase 3 trial found the bispecific immunotherapy teclistamab significantly improved survival and remission in relapsed multiple myeloma, with nearly 70% of patients progression-free at 18 months, outperforming standard therapies.
May 29, 2026
May 29 2026May 28 2026May 27 2026May 26 2026May 25 2026May 22 2026May 21 2026May 20 2026 - Cedars-Sinai Research Identifies Drivers of Liver Disease
- Study Identifies New Marker to Find Patients with Advanced Prostate Cancer More Likely to Benefit From Combination Immunotherapy
- New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease
- The Neural Basis of Thought Symbols Identified for the First Time
- Can Wastewater Surveillance Work Without Sewers?
- First National Study of Home Care Safety for Children with Medical Complexity
- Tumor Microenvironment Features May Predict Immunotherapy Response in Rare Cancers
- Genetically Reengineered Bacteria Targets Cancerous Tumors
- Novel Blood Test Detects Rejection After Lung Transplant
- How Tetracyclines Work: New Study Redefines Mechanism-of-Action
- FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
- In Middle-Aged and Older Adults, Migraine with Aura Associated with Higher Stroke Risk
- Quitting Smoking Associated with Lower Dementia Risk
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Positional Therapy Offers Lasting Benefits for Most Positional OSA Patients
- Early CPAP Struggles Don't Predict Treatment Failure, Study Finds
- Your Handwriting Could Be a Window Into Your Aging Brain
- Nearly 10% of Surgeons are Leaving the Profession Within 8 Years
- Pilot Trial Suggests Anti-Inflammatory Drug Could Help Difficult-to-Treat Depression
- No Meaningful Health Impacts From Exposure to Wind Turbines
- Cytokine-Armored CAR-T Cell Therapy Helps Eliminate Aggressive Brain Tumors in Preclinical Study
- Study Suggests Novel Way to Protect Aging Brains After Surgery
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Could K17 be a Key Treatment Target for Pancreatic Cancer?
- Endocrine Society, Keystone Symposia to Host First Joint Conference in October
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- BGSU Scientists Make Groundbreaking Discovery - and Find a Possible New Ally - in the Opioid Crisis
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Ozone Pollution Limits Lung Benefits of Exercise in Children
- Squeezed and Sped Up: Viscous Stress Primes Glioblastoma Cells for Invasion
- Study: Hospital Wastewater Reveals Drug-Resistant Fungus Strains Months Before Patients Show Symptoms
- Saliva Could Flag One of SA's Deadliest and Baffling Cancers Sooner
- AI Foundation Models Offer a New Vision for Eye Care
May 19 2026May 18 2026May 17 2026May 16 2026May 15 2026
|
|
|
|
|